Iloprost in Acute Respiratory Distress Syndrome

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The patients will be randomized into one of two groups. Both groups will receive standard care as is state of the art. The intervention group will receive Iloprost nebulized as inhalative therapy.
Epistemonikos ID: c1e229bf21f3cd2356fa70e64d93dbd09b7f993b
First added on: Nov 16, 2021